Impact of Frailty on Outcomes in Patients Undergoing Percutaneous Mitral Valve Repair
- PMID: 28917516
- DOI: 10.1016/j.jcin.2017.07.042
Impact of Frailty on Outcomes in Patients Undergoing Percutaneous Mitral Valve Repair
Abstract
Objectives: The aim of this study was to describe the impact of frailty in patients undergoing percutaneous mitral valve repair (PMVR).
Background: Frailty is common in elderly patients and those with comorbidities and is associated with adverse prognosis.
Methods: Frailty according to the Fried criteria was assessed in consecutive patients admitted for PMVR. Associations of frailty with 6-week (device success, changes in 6-min walking distance and Minnesota Living With Heart Failure Questionnaire and Short Form 36 physical and mental component scores, and improvement ≥1 New York Heart Association functional class) and long-term outcomes during a median follow-up period of 429 days were examined.
Results: Of 213 patients admitted for PMVR (median age 78 years; age range 50 to 95 years; 57.3% men), 45.5% were classified as frail. Compared with nonfrail patients, frail patients had a similar device success rate (81.4% vs. 84.5%; p = 0.56) and improvement in 6-min walking distance, New York Heart Association functional class, and Short Form-36 scores but a more pronounced improvement in Minnesota Living With Heart Failure Questionnaire score (mean change -15.9 vs. -11.2 points; p = 0.002). Mortality at 6 weeks was significantly higher in frail (8.3%) compared with nonfrail (1.7%) patients (p = 0.03). Hazards of death (hazard ratio: 3.06; 95% confidence interval: 1.54 to 6.07; p = 0.001) and death or heart failure decompensation (hazard ratio: 2.03; 95% confidence interval: 1.22 to 3.39; p = 0.007) were significantly increased in frail patients during long-term follow-up, which did not change relevantly after adjustment for European System for Cardiac Operative Risk Evaluation score and N-terminal pro-brain natriuretic peptide level.
Conclusions: PMVR can be performed with equal efficacy and is associated with at least similar short-term functional improvement in frail patients. These results support the continued use of PMVR in frail elderly patients with the goal of palliation of heart failure symptoms and improvement in quality of life.
Keywords: MitraClip; frailty; percutaneous edge-to-edge mitral valve repair; quality of life.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Frail Elderly, the Ideal Patients for MitraClip.JACC Cardiovasc Interv. 2017 Oct 9;10(19):1930-1931. doi: 10.1016/j.jcin.2017.08.029. JACC Cardiovasc Interv. 2017. PMID: 28917513 Free PMC article. No abstract available.
Similar articles
-
Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure.Clin Res Cardiol. 2019 Apr;108(4):375-387. doi: 10.1007/s00392-018-1365-5. Epub 2018 Sep 6. Clin Res Cardiol. 2019. PMID: 30191296
-
Elevated Mitral Valve Pressure Gradient After MitraClip Implantation Deteriorates Long-Term Outcome in Patients With Severe Mitral Regurgitation and Severe Heart Failure.JACC Cardiovasc Interv. 2017 May 8;10(9):931-939. doi: 10.1016/j.jcin.2016.12.280. JACC Cardiovasc Interv. 2017. PMID: 28473116
-
Evaluation of cystatin C and neutrophil gelatinase-associated lipocalin as predictors of mortality in patients undergoing percutaneous mitral valve repair (MitraClip).Clin Cardiol. 2018 Nov;41(11):1474-1479. doi: 10.1002/clc.23089. Epub 2018 Nov 16. Clin Cardiol. 2018. PMID: 30284299 Free PMC article.
-
Clinical outcomes of percutaneous mitral valve repair with MitraClip for the management of functional mitral regurgitation.Catheter Cardiovasc Interv. 2019 Nov 15;94(6):820-826. doi: 10.1002/ccd.28203. Epub 2019 Apr 1. Catheter Cardiovasc Interv. 2019. PMID: 30938045 Review.
-
Percutaneous Mitral Valve Repair Vs. Stand-Alone Medical Therapy in Patients with Functional Mitral Regurgitation and Heart Failure.Cardiovasc Revasc Med. 2020 Jan;21(1):52-60. doi: 10.1016/j.carrev.2019.06.008. Epub 2019 Jun 25. Cardiovasc Revasc Med. 2020. PMID: 31326258
Cited by
-
The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure.Can J Cardiol. 2018 Dec;34(12):1648-1654. doi: 10.1016/j.cjca.2018.10.002. Epub 2018 Oct 13. Can J Cardiol. 2018. PMID: 30527154 Free PMC article.
-
Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.J Am Coll Cardiol. 2019 May 7;73(17):2123-2132. doi: 10.1016/j.jacc.2019.02.010. Epub 2019 Mar 17. J Am Coll Cardiol. 2019. PMID: 30894288 Free PMC article. Clinical Trial.
-
Association between natriuretic peptides and C-reactive protein with frailty in heart failure: a systematic review and meta-analysis.Aging Clin Exp Res. 2024 Mar 6;36(1):57. doi: 10.1007/s40520-024-02713-x. Aging Clin Exp Res. 2024. PMID: 38446241 Free PMC article.
-
Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry.JAMA Cardiol. 2018 Dec 1;3(12):1151-1159. doi: 10.1001/jamacardio.2018.3359. JAMA Cardiol. 2018. PMID: 30476950 Free PMC article.
-
Factors associated with improved walking in older people during hospital rehabilitation: secondary analysis of a randomized controlled trial.BMC Geriatr. 2021 Jan 31;21(1):90. doi: 10.1186/s12877-021-02016-0. BMC Geriatr. 2021. PMID: 33517882 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources